Financials GKB Ophthalmics Limited
Equities
GKB
INE265D01015
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
100.4 INR | -0.30% |
|
+4.80% | +0.38% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 481.8 | 429.5 | 216.7 | 413.3 | 463.7 | 547.2 |
Enterprise Value (EV) 1 | 555.8 | 476.8 | 236.6 | 363.7 | 423.1 | 518.2 |
P/E ratio | -49.6 x | -38.9 x | -11.8 x | -45.5 x | 36.4 x | -327 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.62 x | 0.75 x | 0.37 x | 0.73 x | 0.65 x | 0.72 x |
EV / Revenue | 0.72 x | 0.83 x | 0.4 x | 0.64 x | 0.6 x | 0.69 x |
EV / EBITDA | 41.6 x | 28.2 x | 10 x | 15.3 x | 8.55 x | 14.1 x |
EV / FCF | -11.7 x | -5.03 x | -6.6 x | -38.7 x | -25.6 x | -8.45 x |
FCF Yield | -8.51% | -19.9% | -15.2% | -2.58% | -3.9% | -11.8% |
Price to Book | 1.07 x | 0.78 x | 0.37 x | 0.66 x | 0.73 x | 0.87 x |
Nbr of stocks (in thousands) | 4,154 | 4,641 | 5,041 | 5,041 | 5,041 | 5,041 |
Reference price 2 | 116.0 | 92.55 | 43.00 | 82.00 | 92.00 | 108.6 |
Announcement Date | 27/07/18 | 31/08/19 | 04/09/20 | 03/09/21 | 07/09/22 | 22/08/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 774.2 | 574.1 | 585.3 | 568.8 | 709.4 | 754.7 |
EBITDA 1 | 13.37 | 16.9 | 23.57 | 23.83 | 49.52 | 36.83 |
EBIT 1 | -3.302 | -18.39 | -12.57 | -7.568 | 22.85 | 8.561 |
Operating Margin | -0.43% | -3.2% | -2.15% | -1.33% | 3.22% | 1.13% |
Earnings before Tax (EBT) 1 | -11.36 | -15.79 | -18.4 | -9.285 | 19.46 | 1.394 |
Net income 1 | -9.707 | -11.04 | -18.4 | -9.075 | 12.74 | -1.674 |
Net margin | -1.25% | -1.92% | -3.14% | -1.6% | 1.8% | -0.22% |
EPS 2 | -2.337 | -2.379 | -3.650 | -1.800 | 2.528 | -0.3321 |
Free Cash Flow 1 | -47.3 | -94.76 | -35.85 | -9.392 | -16.5 | -61.32 |
FCF margin | -6.11% | -16.5% | -6.12% | -1.65% | -2.33% | -8.12% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 27/07/18 | 31/08/19 | 04/09/20 | 03/09/21 | 07/09/22 | 22/08/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 74 | 47.3 | 19.9 | - | - | - |
Net Cash position 1 | - | - | - | 49.6 | 40.6 | 29 |
Leverage (Debt/EBITDA) | 5.532 x | 2.8 x | 0.8426 x | - | - | - |
Free Cash Flow 1 | -47.3 | -94.8 | -35.8 | -9.39 | -16.5 | -61.3 |
ROE (net income / shareholders' equity) | -2.12% | -2.21% | -3.23% | -1.19% | 2.91% | 0.17% |
ROA (Net income/ Total Assets) | -0.25% | -1.3% | -0.8% | -0.45% | 1.32% | 0.48% |
Assets 1 | 3,875 | 847.5 | 2,291 | 2,006 | 968 | -348 |
Book Value Per Share 2 | 108.0 | 118.0 | 118.0 | 124.0 | 125.0 | 124.0 |
Cash Flow per Share 2 | 5.220 | 20.10 | 26.10 | 11.90 | 11.70 | 4.690 |
Capex 1 | 18.8 | 132 | 38.6 | 63.3 | 47.6 | 16.6 |
Capex / Sales | 2.42% | 22.98% | 6.6% | 11.13% | 6.71% | 2.2% |
Announcement Date | 27/07/18 | 31/08/19 | 04/09/20 | 03/09/21 | 07/09/22 | 22/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+0.38% | 6.06M | |
+15.03% | 101B | |
+20.99% | 43.9B | |
-3.28% | 18.22B | |
-27.64% | 2.02B | |
+11.06% | 1.86B | |
+19.92% | 1.14B | |
+79.32% | 692M | |
-10.11% | 651M | |
-44.02% | 628M |
- Stock Market
- Equities
- GKB Stock
- Financials GKB Ophthalmics Limited